Structural basis for the high-affinity binding of pyrrolotriazine inhibitors of p38 MAP kinase

被引:12
作者
Sack, John S. [1 ]
Kish, Kevin F. [1 ]
Pokross, Matthew [1 ]
Xie, Dianlin [2 ]
Duke, Gerald J. [2 ]
Tredup, Jeffrey A. [2 ]
Kiefer, Susan E. [2 ]
Newitt, John A. [2 ]
机构
[1] Bristol Myers Squibb Co, Res & Dev, Dept Macromol Crystallog, Princeton, NJ 08543 USA
[2] Bristol Myers Squibb Co, Res & Dev, Dept Gene Express & Prot Biochem, Princeton, NJ 08543 USA
来源
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY | 2008年 / 64卷
关键词
D O I
10.1107/S0907444908010032
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The crystal structure of unphosphorylated p38 alpha MAP kinase complexed with a representative pyrrolotriazine-based inhibitor led to the elucidation of the high-affinity binding mode of this class of compounds at the ATP-binding site. The ligand binds in an extended conformation, with one end interacting with the adenine-pocket hinge region, including a hydrogen bond from the carboxyl O atom of Met109. The other end of the ligand interacts with the hydrophobic pocket of the binding site and with the backbone N atom of Asp168 in the DFG activation loop. Addition of an extended benzylmorpholine group forces the DFG loop to flip out of position and allows the ligand to make additional interactions with the protein.
引用
收藏
页码:705 / 710
页数:6
相关论文
共 19 条
[1]  
Adams JL, 2001, PROGR MED CHEM, V38, P1, DOI 10.1016/S0079-6468(08)70091-2
[2]   Recent kinase and kinase inhibitor X-ray structures: Mechanisms of inhibition and selectivity insights [J].
Cherry, M ;
Williams, DH .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (06) :663-673
[3]   Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase [J].
Cumming, JG ;
McKenzie, CL ;
Bowden, SG ;
Campbell, D ;
Masters, DJ ;
Breed, J ;
Jewsbury, PJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (21) :5389-5394
[4]   Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity [J].
Fitzgerald, CE ;
Patel, SB ;
Becker, JW ;
Cameron, PM ;
Zaller, D ;
Pikounis, VB ;
O'Keefe, SJ ;
Scapin, G .
NATURE STRUCTURAL BIOLOGY, 2003, 10 (09) :764-769
[5]   Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38α mitogen-activated protein kinase inhibitors [J].
Hynes, John, Jr. ;
Dyckman, Alaric J. ;
Lin, Shuqun ;
Wrobleski, Stephen T. ;
Wu, Hong ;
Gillooly, Kathleen M. ;
Kanner, Steven B. ;
Lonial, Herinder ;
Loo, Derek ;
McIntyre, Kirn W. ;
Pitt, Sidney ;
Shen, Ding Ren ;
Shuster, David J. ;
Yang, XiaoXia ;
Zhang, Rosemary ;
Behnia, Kamelia ;
Zhang, Hongjian ;
Marathe, Punit H. ;
Doweyko, Arthur M. ;
Tokarski, John S. ;
Sack, John S. ;
Pokross, Matthew ;
Kiefer, Susan E. ;
Newitt, John A. ;
Barrish, Joel C. ;
Dodd, John ;
Schieven, Gary L. ;
Leftheris, Katerina .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (01) :4-16
[6]   p38 map kinases: Key signalling molecules as therapeutic targets for inflammatory diseases [J].
Kumar, S ;
Boehm, J ;
Lee, JC .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (09) :717-726
[7]   Molecular basis for p38 protein kinase inhibitor specificity [J].
Lisnock, JM ;
Tebben, A ;
Frantz, B ;
O'Neill, EA ;
Croft, G ;
O'Keefe, SJ ;
Li, B ;
Hacker, C ;
de Laszlo, S ;
Smith, A ;
Libby, B ;
Liverton, N ;
Hermes, J ;
LoGrasso, P .
BIOCHEMISTRY, 1998, 37 (47) :16573-16581
[8]   AMORE - AN AUTOMATED PACKAGE FOR MOLECULAR REPLACEMENT [J].
NAVAZA, J .
ACTA CRYSTALLOGRAPHICA SECTION A, 1994, 50 :157-163
[9]   Processing of X-ray diffraction data collected in oscillation mode [J].
Otwinowski, Z ;
Minor, W .
MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 :307-326
[10]   Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site [J].
Pargellis, C ;
Tong, L ;
Churchill, L ;
Cirillo, PF ;
Gilmore, T ;
Graham, AG ;
Grob, PM ;
Hickey, ER ;
Moss, N ;
Pav, S ;
Regan, J .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (04) :268-272